Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, has appointed Dr. John Houston as President of Research and Development and Chief Scientific Officer. Dr. Houston, who is a member of the CURE Board of Directors, was most recently a Senior Vice President at Bristol-Myers Squibb … more

A leading life sciences entrepreneur and investment banker, Dr. Mostafa Analoui, will head UConn’s newly launched effort to increase development of new ventures, including UConn’s Technology Incubation Program. Prior to joining UConn, Dr. Analoui served as head of healthcare and life sciences at Livingston Securities … more

Biomedical device startup Mobile Sense Technologies has joined the UConn Technology Incubation Program (TIP). The company will locate its headquarters in the TIP facility at UConn Health in Farmington. Mobile Sense Technologies is commercializing the first “off-the-chest” heart monitor … more